Blueline Advisors’s MediWound MDWD Stock Holding History

Blueline Advisors’s Portfolio MDWD Stock Details MDWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9.9K	Buy	+722	New	+$10K	0.01%	206

Other funds holding MDWD

SBCM

Silverberg Bernstein Capital Management Armonk, New York $211M AUM 58.81% 1-Year Est. Return

PVG Asset Management Golden, Colorado $147M AUM 52.72% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Blueline Advisors's MDWD Position: Q3 2026 in Review

Blueline Advisors opened a new position in MediWound (MDWD) in Q3 2026: 722 shares worth $9.9K. The stake represents 0.01% of the portfolio and ranks #206 among its holdings.

14 funds tracked by Wall St. Rank hold MDWD as of Q3 2026.

Blueline Advisors held 722 shares of MediWound worth $9.9K as of Q3 2026.
MediWound was a new Blueline Advisors position in Q3 2026.
MediWound made up 0.01% of Blueline Advisors's portfolio in Q3 2026, its #206 holding.
14 funds tracked by Wall St. Rank held MediWound as of Q3 2026.

Based on Blueline Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.